Antiangiogenesis agents in clinical trials.
Bence
A K
AK
College of Pharmacy, University of Kentucky, Lexington, USA.
Sheehan
J B
JB
Adams
V R
VR
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000517:prevention & control
D020533:Angiogenesis Inhibitors